与艾滋病相关的卡波西肉瘤复发的纳布-帕克利塔塞尔 - 一个案例报告
Lele Yu1, Binhai Zhang1, Hu Wan1
1Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hangzhou, Zhejiang, 310023, People's Republic of China.
Infection and drug resistance
|April 16, 2024
概括
这项案例研究强调了nab-paclitaxel (Nab-PTX) 作为艾滋病毒/艾滋病患者复发性艾滋病相关卡波西肉瘤 (KS) 的有效治疗方法. 纳布-PTX为这种具有挑战性的癌症提供了一个有前途的治疗选择.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 卡波西肉瘤 (KS) 仍然是艾滋病毒/艾滋病 (PWHA) 患者中重要的癌症,尽管联合抗逆转录病毒疗法 (cART) 的进展.
- 免疫复合炎症综合征 (IRIS) 可能发生在免疫抑制的PWHA启动cART.
- 对复发性艾滋病-KS的有效治疗选择至关重要.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...